FAID 2016 - Precision Medicine & New Technologies : Transforming Clinical Research [fr]

The 2016 French American Innovation Days (FAID) took place on February 9 and 10, 2016 in Cambridge, Massachusetts. This conference was organized by the Office for Science & Technology of the Embassy of France in the United States and the GLOBAL CARE Initiative (a consortium of five non-profit French research institutes), in collaboration with the MIT - France program. The FAID2016 addressed the challenge of Precision Medicine & New Technologies - Transforming Clinical Research.


The conference dealt with the innovative approaches which, building on a state-of-the-art expertise in precision medicine, have been implemented in the industry to develop new medicine and to improve patient care.

The goal of FAID is to bring together small and large companies, high level researchers from some of the best laboratories in France and the US as well as patients’ associations, regulators and government’s stakeholders to highlight the work being done in both countries and to encourage further collaborations.

Find all the pictures of FAID 2016 on the Consulate’s Flickr.

When was it: February 9-10, 2016
Where was it: MIT Media Lab, 75 Amherst St, Cambridge, MA 02139
Program: http://faid2016.france-science.org/program/


The Ambassador of France to the US, Gérard Araud, launched the event on Feb 9th, at 9am. Among the attendees were highly renowned academicians, technology transfer officers, strategic alliances directors and funding/ventures players in healthcare as well as government’s stakeholders. This high-traffic conference broadcasted innovative approaches along with disruptive ways to improve patient care based on state-of-the-art expertise in precision medicine.

Presentation in video below, by Jean-Jacques Yarmoff, scientific attaché at the Consulate general of France in Boston.

Conference highlights


The two-day conference offered extensive networking opportunities to identify partners that would share their insights and inspirations on the major trends of the challenging healthcare industry.

  • Sessions with keynotes, case studies, interactive panel discussions featuring renowned scientists of the field.
  • Mini showcase of 2 to 3 minutes overviews of different French or American institutions, companies and start-ups determined to make a difference in advancing precision medicine.


Amongst the speakers:

  • Yves Agid - MD, PhD, Scientific Director of ICM, Clinician and Neuroscientist
  • Christian Bréchot - MD, PhD, President, Institut Pasteur
  • Christophe Le Tourneau - Head, Early Trials, Institut Curie, Principal Investigator of Shiva trial
  • Sergio Roman-Roman - Head, Translational Research, Institut Curie
  • Emanuela Romano - Head, Immunotherapy Unit, Institut Curie, Development of anti-checkpoint
  • José-Alain Sahel - Director, Institut de la Vision, Conducting research in retinal degenerative diseasesGilles Salles - Founder of CALYM
  • Stéphane Bancel - Founding CEO, Moderna
  • Christopher Larkin - CTO, GE Healthcare
  • Jonathan Stamler - Director, Harrington Discovery Institute
  • Pierre Tervé - VP Technic & Scientific Advisor, Keosys
    See the full list of participants : http://faid2016.france-science.org/speakers/


About FAID

FAID is an annual Franco-American event which brings together scientists, companies, entrepreneurs and investors. It is a high-level event in the Boston area where researchers and companies have the opportunity to exchange views on a specific technological issue, start cooperative activities and develop business transactions with a transatlantic perspective. The goal of the program is to facilitate the development of innovation ties between France and America.

About GLOBAL CARE Initiative

GCI is a consortium of five Carnot Human Health Institutes that covers four therapeutic fields in human health markets : cancer, vision and audition diseases and rehabilitation, infectious diseases and central nervous system diseases. GCI brings together 2,500 researchers and a wide array of technical assets and expertise and drives a budget of €31 million for international business development and research.

Last modified on 17/02/2016

top of the page